We are live on ! Find out more
ATXS

Astria Therapeutics

Delisted

ATXS was delisted on the 22nd of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$17.3M +$6.5M +678,454 +53%
RCM
2
RA Capital Management
Massachusetts
$11.2M +$2.6M +270,883 +27%
FFM
3
Fairmount Funds Management
Pennsylvania
$8.06M +$2.2M +229,708 +34%
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.9M +$4.01M +418,782 +310%
CAM
5
Cormorant Asset Management
Massachusetts
$4.89M -$371K -38,764 -7%
VA
6
VR Adviser
New York
$4.76M -$10 -1 -0%
Citadel Advisors
7
Citadel Advisors
Florida
$2.75M -$151K -15,752 -5%
CC
8
Commodore Capital
New York
$2.12M -$290K -30,230 -11%
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$1.99M +$160K +16,666 +8%
SCM
10
Soleus Capital Management
Connecticut
$994K -$160K -16,668 -13%
Renaissance Technologies
11
Renaissance Technologies
New York
$967K +$445K +46,443 +74%
IC
12
Ikarian Capital
Texas
$775K -$10.9K -1,136 -1%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$535K +$278K +29,063 +92%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$407K +$441K +46,070 New
BlackRock
15
BlackRock
New York
$363K +$17.1K +1,780 +5%
AG
16
Artal Group
Luxembourg
$295K +$319K +33,333 New
AI
17
ArchPoint Investors
Florida
$250K +$4.6K +480 +2%
SB
18
Samsara BioCapital
California
$221K
GCP
19
GSA Capital Partners
United Kingdom
$221K +$239K +24,996 New
Northern Trust
20
Northern Trust
Illinois
$170K +$49.8K +5,193 +37%
OQS
21
Occudo Quantitative Strategies
Florida
$137K +$92.1K +9,613 +164%
OC
22
Oppenheimer & Co
New York
$108K +$19.2K +1,999 +20%
OWP
23
Old Well Partners
North Carolina
$107K +$116K +12,116 New
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
$106K -$10 -1 -0%
Goldman Sachs
25
Goldman Sachs
New York
$99K -$21.4K -2,232 -17%